Chief Commercial Officer · Day One Biopharmaceuticals, Inc. · Common Stock
Side
D
Value
—
Shares
60.2K
Price
—
Executed
Apr 23, 2026
Disclosed
Apr 23, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Apr 23 executedApr 23, 2026 disclosed
DAWN · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disposition to issuer — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Merendino Lauren filed this Form 4 reporting a disposition to issuer of DAWN on Apr 23, 2026. It became public on Apr 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Merendino Laurencik:0001855298
Issuer
Day One Biopharmaceuticals, Inc.cik:0001845337
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for DAWN is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
